The ability of Pseudomonas aeruginosa to develop resistance to most antimicrobials represents an important clinical threat worldwide. We report the dissemination in several Colombian hospitals of two predominant lineages of extensively drug-resistant (XDR) carbapenemase-producing P. aeruginosa strains. These lineages belong to the high-risk clones sequence type 111 (ST111) and ST235 and harbor bla VIM-2 on a class 1 integron and bla KPC-2 on a Tn4401 transposon, respectively. Additionally, P. aeruginosa ST1492, a novel single-locus variant of ST111, was identified. Clonal dissemination and the presence of mobile genetic elements likely explain the successful spread of XDR P. aeruginosa strains in Colombia.
P
seudomonas aeruginosa is an opportunistic pathogen associated with a variety of hospital-associated infections, often in critically ill patients. The treatment of infections caused by P. aeruginosa is challenging due to the expression of metallo-␤-lactamases (e.g., VIM and IMP) and serine enzymes (e.g., Klebsiella pneumoniae carbapenemase [KPC] ) that confer resistance to most commercially available ␤-lactams. The acquisition of carbapenemase-encoding genes, combined with the presence of mechanisms of resistance to multiple other antimicrobials, has led to the emergence of multidrug-resistant (MDR) and extensively drugresistant (XDR) P. aeruginosa (1) . Clinicians are often left with very limited options to treat infections caused by MDR and XDR P. aeruginosa strains, which are associated with increased morbidity, mortality, and health care costs (2, 3) .
Studies on the molecular epidemiology and population structure of Gram-negative bacteria have identified MDR strains that successfully disseminate across diverse geographic locations and patient populations and are therefore known as high-risk clones. Genetic fingerprinting with multilocus sequence typing (MLST) has identified sequence type 111 (ST111), ST175, and ST235 as high-risk clones that are prevalent among carbapenemase-producing P. aeruginosa strains from Europe and Asia (4-7). Carbapenem-resistant P. aeruginosa, mainly mediated by KPC-and VIMtype enzymes, is endemic in Colombia (8, 9) . Although initial reports suggested that high-risk clones circulate in Colombia (10, 11) , data on the molecular epidemiology of carbapenemase-producing P. aeruginosa isolates are limited. In this study, we characterize XDR P. aeruginosa isolates from seven cities in Colombia, focusing on the identification of high-risk clones and of genetic elements associated with the dissemination of carbapenemase genes.
Single-patient isolates of XDR P. aeruginosa (defined as resistant to antipseudomonal carbapenems, cephalosporins, penicillins, fluoroquinolones, and aminoglycosides [1] ) were selected from the Colombian Bacterial Resistance Surveillance Network strain collection (2008 and 2010) at the Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM). A total of 161 isolates were recovered from 16 tertiary care hospitals in seven Colombian cities. The majority of the isolates (77%) were from intensive care units, and the most frequent sample sources were urine (n ϭ 40), blood (n ϭ 36), respiratory secretions (n ϭ 34), and skin or soft tissue (n ϭ 17). The study was approved by the ethics committee of CIDEIM.
An in-house multiplex quantitative PCR (qPCR) designed to detect bla KPC , bla VIM , bla IMP , bla NDM , bla TEM , bla SHV , and bla CTX-M was performed using a CFX96 real-time PCR detection system (Bio-Rad Laboratories, Hercules, CA). The probes (duallabeled black hole quencher [BHQ] probes) and primers (Table 1) were designed using Beacon Designer 8.0 (Premier Biosoft International). Total DNA (100 ng) was used as the template for the reaction. The thermal cycling conditions for the multiplex qPCR were 50°C for 2 min, 95°C for 2 min, followed by 40 cycles at 95°C (15 s) and 60°C (1 min). The samples with a threshold cycle (C T ) value of Ͻ35 were considered positive. Additionally, conventional PCR was used to screen for the presence of bla PER and bla GES (12) . We performed phenotypic tests for carbapenemase production using the Carba NP test and a combined-disk method (CDM) using imipenem and cloxacillin in isolates that tested negative for the presence of carbapenemase genes (13, 14) . The sequencing of PCR products was performed in order to confirm the identities of the detected genes. Pulsed-field gel electrophoresis (PFGE) using XbaI was performed in the 161 isolates to assess their genetic relatedness, as previously described by Gautom (15) . Two or more strains were considered genetically related if the Dice coefficient was Ͼ75%. MLST was performed in at least one isolate from each PFGE type, as described previously (15) . STs were assigned using the available Web-based scheme (Pseudomonas aeruginosa MLST database [http://pubmlst.org/paeruginosa]). The location of carbapenemase genes within the bacterial chromosome was investigated with S1 nuclease/I-CeuI probe hybridization using previously described protocols (16, 17) , and the genetic environment surrounding bla VIM or bla KPC was further analyzed by PCR and sequencing (11, 18) .
PCR amplification and sequencing confirmed the presence of bla VIM-2 and bla KPC-2 in 128 out of 161 isolates that fit the definition of XDR P. aeruginosa (1) . Of note, isolate 3386 was found to harbor both bla VIM-2 and bla KPC-2 , as previously described in detail (10) . All isolates that tested negative for the presence of carbapenemase genes by PCR were also negative for carbapenemase production, according to phenotypic tests (Carba NP and CDM). We did not characterize these isolates further, but we suspect that their phenotype can be explained by the hyperexpression of the MexAB-OprM efflux pump, modification of the OprD2 porin, and cephalosporinase hyperproduction, as described elsewhere (14, 19) . PFGE revealed 18 different types, seven of which were represented by single isolates. Seven PFGE types contained isolates with bla VIM-2 , and six contained isolates with bla KPC-2 . As mentioned above, one isolate harbored both bla VIM-2 and bla KPC-2 , but other isolates from the same PFGE type (PTG2) harbored bla VIM-2 only. Among 12 isolates in PFGE type PTG1, only one contained bla VIM-2 , whereas carbapenemase-encoding genes were not found in the remaining isolates. We were not able to detect carbapenemase genes in the isolates belonging to four PFGE types (Table 2) .
We selected 32 isolates (at least one from each PFGE type) for further typing with MLST; 13 of these isolates harbored bla VIM-2 only, 10 isolates harbored bla KPC-2 only, and one isolate harbored both bla VIM-2 and bla KPC-2 . Eight isolates were negative for all the carbapenemases tested. MLST indicated that 86% of the P. aeruginosa strains harboring bla VIM-2 belonged to ST111 (n ϭ 11), while all P. aeruginosa strains carrying bla KPC-2 belonged to ST235. Interestingly, a novel single-locus variant of ST111 (designated ST1492) was identified in one isolate. Carbapenem-resistant P. aeruginosa isolates that did not carry any of the target genes belonged to ST111, ST235, ST481, and ST227 ( Table 2 ). All these sequence types have Ͼ3 allele differences and are considered unrelated.
Using an S1/I-CeuI hybridization protocol, we were able to determine that bla VIM-2 and bla KPC-2 were located in the chromosome in the majority of the isolates (70%). In the remaining isolates, these genes were located in plasmids of variable length (80 to 190 kb). In the 12 isolates belonging to P. aeruginosa ST111, bla VIM-2 was found in a class 1 integron with aacA29a in the upstream region and aacA29b and qacE⌬1sul-1 in the downstream region; this genetic structure was previously designated In59 (10, 20) . The transposon Tn4401 was found in 8 isolates carrying bla KPC-2 ; in the two remaining isolates, bla KPC-2 did not appear to be associated with this genetic structure ( Table 2) .
The emergence of MDR and XDR bacteria causes alarm and is deemed a global public health crisis. Colombia is a particular hotspot for antibiotic resistance, where the acquisition of genes coding for KPC and VIM enzymes among Enterobacteriaceae and P. aeruginosa is of great concern (8-11, 18, 21-23) . Previous reports (24, 25) described the predominance of certain genetic lineages of P. aeruginosa in various clinical settings and geographic locations; P. aeruginosa ST111 and ST235, mostly harboring bla VIM and other metallo-␤-lactamases, have been identified as being among these high-risk clones (4, (26) (27) (28) (29) (30) . Similar to findings elsewhere, our survey of P. aeruginosa from Colombian hospitals found that ST111 is a common host of bla VIM-2 . In contrast, we found that P. aeruginosa ST235 is most commonly associated with the dissemination of bla KPC-2 and is present in hospitals from 6 out of the 7 cities included in our study (see Fig. S1 in the supplemental material). Although we had previously identified other P. aeruginosa STs (ST308, ST1006, and ST1060) associated with the dissemination of bla KPC-2 , this more comprehensive survey revealed that ST235 is the predominant carbapenemase-producing P. aeruginosa strain type in Colombia. P. aeruginosa ST235 harboring other carbapenemase-encoding genes, such as bla VIM , bla IMP , and bla GES , has been reported in other countries (8, 30) . Of note, the set of XDR P. aeruginosa strains analyzed in this survey displayed consistent susceptibility to polymyxin B (except for isolate 3386 that harbors both bla VIM-2 and bla KPC-2 ), indicating that polymyxins remain one of the few options for the treatment of infections caused by XDR P. aeruginosa strains in Colombia.
In summary, VIM-2 and KPC-2 carbapenemases are the main contributors to ␤-lactam resistance among XDR P. aeruginosa strains found in Colombian hospitals. Almost all P. aeruginosa strains harboring bla VIM-2 belong to ST111, while a single se- . These XDR high-risk clones mainly rely on class 1 integrons and the well-known transposable element Tn4401 as the principal structures for gene mobilization. The coexistence of these lineages of XDR P. aeruginosa in this South American country suggests complex transmission dynamics that need to be explored further. Our findings indicate that the spread of XDR P. aeruginosa high-risk clones is a real threat in Colombian hospitals; this knowledge should serve as the basis for nationwide strategies to improve infection prevention and control efforts.
